DRUG · Unmapped registry intervention
BR1018A
Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
NCT06165250
Drugs and interventions used in this trial
6 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
BR1018A-1
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
BR1018B
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
BR1018B-1
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
BR1018C
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
BR1018C-1
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Primary Hypercholesterolemiaunresolved
Interventions
Sponsors & collaborators
Boryung Pharmaceutical Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06165250 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.